McKesson, Cardinal Health and AmerisourceBergen were accused of ignoring shipments of painkillers being diverted to illegal channels, while J&J allegedly downplayed the the risk of addiction in its marketing materials for opioids, which the firm stopped making in 2020. All companies have denied the allegations.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?